Atopius Health is a biotechnology company on a mission to transform the way therapeutics are discovered. By studying the remarkable diversity of metabolites produced by microbes across Earth’s ecosystems, we uncover evolutionarily conserved blueprints for small‑molecule design.
Our research harnesses nature’s own chemistry, using microbial metabolites as inspiration for the next generation of precision therapies. We believe that the molecules honed by billions of years of evolution hold the key to more effective, safer drugs for diseases lacking robust treatment options.
We start by exploring the chemistry of microbes, mining their metabolites for unique scaffolds and functional motifs that have persisted through evolutionary pressure. These natural blueprints guide our discovery efforts.
Using insights from microbial metabolites, we craft small molecules with targeted activity and favourable pharmacology. Precision engineering ensures our molecules interact selectively with their intended biological targets.
Our pipeline focuses on areas of high unmet need, where current treatments fall short. We strive to translate microbial wisdom into therapies that improve patient outcomes across a variety of disease states.
Interested in learning more about our science or partnering with us? Reach out using the form below and our team will be in touch.
